Meryl Horne

Paul Glu, a professor at the University of Otago in New Zealand, is the one who explained this to me.

What this can all lead to when things really go south.

We don't know how likely it is that you'll die from taking Ibogaine.

Like, yes, we have...

documented deaths from people taking Ibogaine because of this thing that happens with the heart.

Researchers have been kind of collecting case studies here and there to try to figure out how often it's happening so you can kind of add up all these documented deaths.

Yeah, since we've been researching this.

It's both.

So there have been a couple documented deaths from people taking it in West Africa, and this is generally a known possibility among people who practice britsi and take iboga during rituals.

though it is rare.

And so Paul wanted to know, like, can we get around this?

Can we get the benefits of Ibogaine without this risk?

Like, is there a dose we can give that's safe?

Right.

So he did a study.

He's the one who did this, you know, placebo-controlled randomized clinical trial.

Okay, so what did he do?

So he teamed up with a pharma company that was interested in making this drug.

They actually used a slightly different version of the chemical called

So Ibogaine itself, you know, no drug company is interested in making that into a drug because it can't be patented since a researcher did that like years ago already, sort of like a pharma cock block.